With a PhD in Pharmacy (Barcelona University), Anna initiated her career on clinical research after her Master of Science in Biopharmacy at King’s College (University of London, UK) in 1992. Additional degrees include the Executive Educational Program at Wharton Business School (University of Pennsylvania, USA), Finance for Directors at ESADE Business School (Barcelona), Six Sigma Green Belt Award within the Corporate Quality Improvement department of the United Health Group (Salt Lake City, USA) and PMP® from Project Management Institute® (Pennsylvania, USA).
Anna has proven expertise to promote and execute clinical trials with risk-based approach, 6σ and PMI methodology, to cut down investment costs while maintaining quality across all project life cycle. As director has driven more than 42 clinical trials in multiple indications and lead Functional Services Provision, from Drug Early Development to Commercialization. Since 1988, she has assumed multiple roles at Pharma Industry (Laboratorios Boiron, Parke Davis, Laboratorios Cusí, Bieffe Medital) and Clinical Research Organizations (Ingenix, Inventiv Health), from Technical Director, Quality Assurance, Clinical Research Operations and Innovative scientific medical knowledge enterprises, such as MedSIR.
Over the last 25 years she has managed clinical trials for more than 40 pharmaceutical companies worldwide and clinical research teams in Europe, South America and Asia Pacific region for drug development in oncology, neuroscience, cardiovascular, vaccines, metabolic and infectious diseases among other therapeutic areas from phase 0 to IV.
Since 2012 Anna collaborates as Scientific Director of the Master in Clinical Research and Medical Affairs organized by CESIF.